These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 9830205)

  • 1. Dengue vaccine design: issues and challenges.
    Cardosa MJ
    Br Med Bull; 1998; 54(2):395-405. PubMed ID: 9830205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Editorial: the challenge of dengue vaccine development and introduction.
    Deen JL
    Trop Med Int Health; 2004 Jan; 9(1):1-3. PubMed ID: 14728601
    [No Abstract]   [Full Text] [Related]  

  • 3. Of cascades and perfect storms: the immunopathogenesis of dengue haemorrhagic fever-dengue shock syndrome (DHF/DSS).
    Pang T; Cardosa MJ; Guzman MG
    Immunol Cell Biol; 2007 Jan; 85(1):43-5. PubMed ID: 17130899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a novel DNA SynCon tetravalent dengue vaccine that elicits immune responses against four serotypes.
    Ramanathan MP; Kuo YC; Selling BH; Li Q; Sardesai NY; Kim JJ; Weiner DB
    Vaccine; 2009 Oct; 27(46):6444-53. PubMed ID: 19580892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The future of dengue vaccines.
    Halstead SB; Deen J
    Lancet; 2002 Oct; 360(9341):1243-5. PubMed ID: 12401270
    [No Abstract]   [Full Text] [Related]  

  • 6. Progress towards a dengue vaccine.
    Webster DP; Farrar J; Rowland-Jones S
    Lancet Infect Dis; 2009 Nov; 9(11):678-87. PubMed ID: 19850226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dengue virus vaccine development.
    Yauch LE; Shresta S
    Adv Virus Res; 2014; 88():315-72. PubMed ID: 24373316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dengue virus non-structural protein 1: a pathogenic factor, therapeutic target, and vaccine candidate.
    Chen HR; Lai YC; Yeh TM
    J Biomed Sci; 2018 Jul; 25(1):58. PubMed ID: 30037331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune correlates of protection for dengue: State of the art and research agenda.
    Katzelnick LC; Harris E;
    Vaccine; 2017 Aug; 35(36):4659-4669. PubMed ID: 28757058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Challenges for the formulation of a universal vaccine against dengue.
    Chokephaibulkit K; Perng GC
    Exp Biol Med (Maywood); 2013 May; 238(5):566-78. PubMed ID: 23856907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Advances in the development of a vaccine against dengue].
    Guzmán MG
    Acta Cient Venez; 1998; 49 Suppl 1():38-45. PubMed ID: 10030053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dengue vaccine.
    Simasathien S; Watanaveeradej V
    J Med Assoc Thai; 2005 Nov; 88 Suppl 3():S363-77. PubMed ID: 16858980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of new vaccines against dengue fever and Japanese encephalitis.
    Kinney RM; Huang CY
    Intervirology; 2001; 44(2-3):176-97. PubMed ID: 11509879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of dengue virus infection and its control.
    Igarashi A
    FEMS Immunol Med Microbiol; 1997 Aug; 18(4):291-300. PubMed ID: 9348165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A chimeric tetravalent dengue DNA vaccine elicits neutralizing antibody to all four virus serotypes in rhesus macaques.
    Raviprakash K; Apt D; Brinkman A; Skinner C; Yang S; Dawes G; Ewing D; Wu SJ; Bass S; Punnonen J; Porter K
    Virology; 2006 Sep; 353(1):166-73. PubMed ID: 16814355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Development of immunizing agents against dengue].
    López Antuñano FJ; Mota J
    Rev Panam Salud Publica; 2000 May; 7(5):285-92. PubMed ID: 10893968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Experimental in vitro and in vivo systems for studying the innate immune response during dengue virus infections.
    Kitab B; Kohara M; Tsukiyama-Kohara K
    Arch Virol; 2018 Jul; 163(7):1717-1726. PubMed ID: 29520688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dengue tetravalent DNA vaccine inducing neutralizing antibody and anamnestic responses to four serotypes in mice.
    Konishi E; Kosugi S; Imoto J
    Vaccine; 2006 Mar; 24(12):2200-7. PubMed ID: 16316713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dengue hemorrhagic fever - A systemic literature review of current perspectives on pathogenesis, prevention and control.
    Wang WH; Urbina AN; Chang MR; Assavalapsakul W; Lu PL; Chen YH; Wang SF
    J Microbiol Immunol Infect; 2020 Dec; 53(6):963-978. PubMed ID: 32265181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaccines licensed and in clinical trials for the prevention of dengue.
    Torresi J; Ebert G; Pellegrini M
    Hum Vaccin Immunother; 2017 May; 13(5):1059-1072. PubMed ID: 28281864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.